Marcin Goszyk

Marcin Goszyk is the current Director at ArchiMed. Prior to this, they were the Investment Director at Corviglia Capital Fund from April 2018 to December 2019. Before that, they were with Innova Capital from June 2016 to December 2017 as their Investment Director. Marcin has also been a Principal with The Riverside Company from February 2007 to May 2016. Additionally, they have experience as a Senior Associate Corporate Finance with PwC from July 2003 to January 2007 and an Intern with The Coca-Cola Company from July 2002 to September 2002.

Marcin Goszyk has a Global Executive MBA from INSEAD and a Drug Discovery & Medicinal Chemistry Certificate from edX. Marcin also has an Oxford Fintech Programme from Saïd Business School at the University of Oxford and a Postgraduate Diploma in Coaching and Mentoring from Uniwersytet SWPS. Lastly, they have a Master of Science in Finance from Wroclaw University of Economics and Business.

They work with Anthony Farias - Associate Director, Thilo Paas - Analyst, and Javier Martinez - Senior Analyst. Marcin Goszyk reports to Ludovic Alonzi, Director, Investment.